Why Texas Instruments' Big Beat Still Left the Stock Lower

On July 22, Texas Instruments reported a second quarter that topped Wall Street on nearly every line — and the stock fell about 3% in after-hours trading anyway. That disconnect is worth sitting with, because it is the whole story in miniature: the beat tells you something real about the recovery under way, and the selloff tells you something real about what the market had already priced in.

First, the business, because it shapes everything else. Texas Instruments is the quiet giant of chips. It doesn't make the flashy processors that power your phone's brain; it makes the analog chips that manage power, convert signals, and act as the glue inside almost every electronic device built. Those chips are cheap individually and unglamorous, but TI sells thousands of them to tens of thousands of customers across industrial, automotive, personal electronics, and communications — no single buyer drives the story. That diversification is the reason its revenue is cyclical rather than binary: when a wave of industrial and auto demand turns down, it shows up everywhere at once, and when it turns up, it lifts the whole base together.

The downcycle ran through 2024 and 2025, and it was compounded by a decision of TI's own making. Management spent the downturn pouring billions into new 300mm fabs — capacity that came online before demand had recovered, weighing on margins in the short term in exchange for structurally cheaper chips over the long term. That is the context for what this quarter actually showed.

The beat, and what it carried

Q2 revenue came in at $5.46 billion, up 13% sequentially and 23% from a year earlier — ahead of the roughly $5.2 billion analysts expected. Adjusted earnings of $2.09 per share beat the consensus of about $1.92. The growth was broad: industrial was up about 30% year over year, automotive was inflecting higher, and data-center sales doubled, a newer leg for TI tied to power-management demand in AI builds.

The most important number was the gross margin — the share of each revenue dollar left after manufacturing cost. It jumped 340 basis points sequentially to 61%. That is the tell. TI's margin was artificially low during the cycle trough because it was running new, expensive fabs at low utilization. As demand fills those factories and pricing recovers, the margin climbs back toward its long-run level. A 61% gross margin is evidence not of one good quarter but of the operating leverage embedded in the company's structure.

Free cash flow — the cash a company generates after paying to build its factories — jumped 271% on a trailing-twelve-month basis to $6.53 billion. One discipline note here: a meaningful slice of that, roughly $1.6 billion over the trailing year, came from U.S. CHIPS Act investment tax credits rather than from selling chips. The improvement is genuinely large; it is just not quite as large as the headline flatters. Slice out the credits and the underlying recovery still looks strong — but know the denominator you're looking at.

And the quarter kept the shareholder machine intact: TI raised its dividend for a 22nd consecutive year, with a yield near 2%, paid out $1.3 billion in the quarter, and guided third-quarter revenue to $5.65–6.15 billion against an estimate near $5.61 billion.

Why the market shrugged

None of that is a mystery to explain — the beat is real — which is precisely why the flat stock reaction matters. The market prices the next step, not the last one. Coming into the report, TI shares were up roughly 64% for 2026 after a run from the mid-$150s area to the low $300s. A lot of the recovery was already sitting in the price. The third-quarter guide, though above consensus, was a continuation of an improving path rather than a step change, and management flagged that price increases were only beginning and would contribute little to Q3's top line.

So the selloff is less a verdict on the quarter and more a reflection that the easy part of the move had already happened. That is the distinction a holder and a would-be buyer each need to draw: the beat confirms the recovery has legs; it does not, by itself, make the stock cheap.

The investment case isn't a quarter

This is the core of it. TI's case was never built on any single quarter's beat — it is a multi-year story about compounding. Management is explicit that the north-star metric is growth in free cash flow per share, and every recent decision funnels into that: gross margins recovering toward the mid-60s as utilization climbs, the 300mm buildout cutting chip costs roughly 40% over time, price increases starting to take hold, and a 22-year dividend growth streak that anchors the shareholder-return promise.

The Q2 number is evidence that fits inside that case — it showed the margin recovery, the pricing power, and the free-cash-flow compounding all moving in the right direction at once. What it is not is a change to the case. The long-term thesis is intact, but an intact long-term thesis doesn't by itself justify buying here. At a premium valuation after a roughly 64% run, the operative question is whether the next twelve months of margin and cash-flow improvement are already on the ticket — and whether that near-term return curve beats what your capital can do elsewhere.

The beat settles the direction. It doesn't settle the price you pay for it. That second judgment, on timing and valuation rather than on the company, is the one still open — and it's the one that decides whether this quarter moves the needle for your portfolio at all.